Health Legislation

The law defines the legal framework for the prevention and comprehensive care of the human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS). The law includes the rights and obligations of people living with HIV as well as the prevention and prohibition of discriminatory practices. The law includes as well the treatments in the health system in Cabo Verde among other issues.

This Act makes provision for the prevention and management of HIV and AIDS; provides for the rights and obligations of persons living with HIV or affected by HIV and AIDS; provides for the establishment of the National AIDS Commission; and provides for matters incidental thereto or connected therewith.

This Law establishes the rules for the efficient and safe production, distribution, use and availability, as well as quality assurance of medicines, vaccines, biological and health products for citizens.

The Ghana AIDS Commission Act, 2016 is to establish the Ghana AIDS commission and the National HIV and AIDS Fund, to provide for the management of the Fund, to prevent and control the HIV and AIDS epidemic, to promote and protect the rights of persons living with HIV or AIDS and to provide for related purposes.

The purpose of the law is to determine the fundamental principles of the control of HIV and AIDS in Niger.

The Act regulates the quality and safety of medicines and related products and connected matters.

This Act provides for the registration, regulation of the sale, distribution, importation, exportation, manufacture and dispensing of medicines and related substances, and matters incidental thereto.

The purpose of this Act is to determine the fundamental principles relating to the protection of the rights of people living with HIV/AIDS and of persons affected.

This Act provides for prevention, treatment, care, support, and control of HIV and AIDS, for promotion of public health in relation to HIV and AIDS; provides for appropriate treatment, care and support using available resources to people living with or at risk of HIV and AIDS and provides for related matters.

The law makes rules on HIV/AIDS Prevention, Treatment and Control.

This Act amends the Medicines and Related Substances Control Act, 2003, so as to amend and delete certain definitions; provides for a period within which the Council must be appointed; provides for the appointment of chairpersons of committees established by the Council; amends provisions relating to the classification of medicines and other substances as scheduled substances; amends provisions relating to the manufacturing, packing and selling of specified Schedule 3 and specified Schedule 4 substances; deletes references to generic substitutions; substitutes references to Schedule 1, Schedule 2, Schedule 3 or Schedule 4 medicines by references to Schedule 1, Schedule 2, Schedule 3 or Schedule 4 substances; inserts provisions relating to the registration of premises engaged in the manufacturing of medicines; amends provisions relating to offences and penalties; amends provisions relating to the destruction of forfeited medicines, scheduled substances or other things; provides for the making of regulations in relation to medicines; amends provisions relating to the exclusion of medicines from the operation of the Act; amends the transitional provisions; amends provisions relating to the repeal and amendment of certain laws; and provides for matters incidental thereto.

This decree regulates the marketing authorization, registration, manufacture, import, export, marketing, donations and advertising of medicines for human use.

This Act provides measures for the prevention, management and control of HIV and AIDS, provides for the protection and promotion of public health and the appropriate treatment, counselling, support and care of persons infected or at risk of HIV and AIDS infection, and connected purposes.

The purpose of this law is to combat the spread of the disease caused by the Human Immunodeficiency Virus (HIV) leading to the reduction and loss of the body's immune defenses, resulting in Acquired Immunodeficiency Syndrome (AIDS); to protect people living with HIV/AIDS against all forms of discrimination or stigmatization; and to reaffirm their fundamental rights and freedoms in accordance with international human rights instruments.

The purpose of this Law is to create a legal framework that allows for the implementation of the actions and mechanisms necessary for the education, prevention, treatment, epidemiological surveillance, research, care and monitoring of sexually transmitted infections and HIV/AIDS, as well as to guarantee respect, protection and defence of human rights, and to eliminate the stigmatization and discrimination of people infected with HIV/AIDS. This law can be located on page 24 of the file.

The scope of application of this Law includes: medicines and health products, as well as the actions of natural and legal persons involved in the production, marketing, prescription and dispensing of pharmaceutical and health products within the national territory. This document is published as a part of a compilation of laws and decrees and this Law is located on page 2 of the file.

This Act provides for the efficient and comprehensive regulation and control of food, drugs, medical devices, cosmetics, herbal drugs and poisons and repeals the Food (Control of Quality) Act, 1978, the Pharmaceuticals and Poisons Act, 1978, and provides for related matters.

This proclamation provides rules to control drugs, medical supplies and sanitary items.

This Act establishes the Medical Stores Department for the procurement, storage and distribution of medical supplies and provides for other matters connected or incidental to the establishment and management of the department.

The Act provides for the registration and control of medicines and related substances for human and animal use, establishes the Medicines Control Council, and outlines its powers and responsibilities. It includes provisions for the licensing of manufacturers, distributors, and dispensers, as well as measures to ensure the availability of affordable medicines. The Act also addresses the regulation of medicine pricing, generic substitution, labeling, and procedures for appeals and re-evaluation of registered medicines.